newsfilter
← Latest News
GlobeNewswire·

Pluristem Brings ARDS Associated with COVID-19 Phase II Studies to Clinical Readout

The company will analyze data based on patients enrolled to date in COVID-19 Phase II studies in U.S., Europe and Israel Topline results are expected during the fourth quarter of 2021 HAIFA, Israel, July 08, 2021 (GLOBE NEWSWIRE) -- Pluristem The